The Philadelphia Eagles face uncertainty as Jalen Hurts, their Super Bowl MVP quarterback, is expected to miss the remainder of the 2026 season due to blood clots in his lungs. The situation escalated after Hurts suffered a calf injury during Week 4 against the Los Angeles Rams but did not seek medical treatment until days later. Following the team's game against the Jacksonville Jaguars in London, an ultrasound revealed a superficial blood clot, yet he was cleared to play.

Hurts experienced complications after flying back to Philadelphia, where further tests indicated deep vein thrombosis and blood clots in both lungs. Consequently, he has been placed on blood thinners and is now sidelined for the season.

In a press conference, Eagles head coach Nick Sirianni addressed concerns about Hurts' ability to travel and play despite his condition. Sirianni emphasized the team's commitment to player health, stating:

The health of our players is always at the forefront of our minds. We always put the players' health first and foremost in every situation.

Key unanswered questions remain:

• Will the Eagles' executives or medical staff provide further details?
• Why was Hurts allowed to fly home despite the risks associated with air travel?
• Is there a timeline for Hurts' return to play in 2027?

According to Nicole Lynn, Hurts' agent, the prognosis is positive, with expectations for a complete recovery. The Eagles are optimistic that Hurts can resume football activities once off blood thinners. This situation echoes that of Victor Wembanyama, who successfully returned to play after a similar health scare, offering hope for Hurts’ future on the field.